Good Sense Eye Drops Recalled for Lack of Sterility Assurance
K.C. Pharmaceuticals is recalling Good Sense Eye Drops Irritation Relief and related brands due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II due to a lack of assurance of sterility in eye drops, a hazard that may cause temporary or medically reversible adverse health consequences. The source does not report any illnesses, injuries, or deaths.
Plain-English summary
K.C. Pharmaceuticals, Inc. is recalling Good Sense Eye Drops Irritation Relief (tetrahydrozoline HCl, zinc sulfate) and several other branded eye drop products, including Equaline, H.E.B A.C. Eye Drops, QC-Quality Choice, and TopCare health. The recall involves 182,016 cartons of 0.5 fl. oz. (15 mL) bottles distributed nationwide in the United States.
The recall was initiated due to a lack of assurance of sterility in the affected products. The source text does not report any illnesses, injuries, or deaths associated with this recall.
Consumers should stop using the recalled eye drops and return them to the place of purchase for a refund or contact the recalling firm for further instructions.
The recalled product
- Product
- GOODSENSE EYE DROPS IRRITATION RELIEF (TETRAHYDROZOLINE HCL, ZINC SULFATE)
- Brand
- GOODSENSE EYE DROPS IRRITATION RELIEF
- Manufacturer
- K.C. Pharmaceuticals, Inc.
- Category
- Drug — Ophthalmic
- Hazard
- Affected units
- 182,016
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lot: a) AC25C01
- Exp.: 3/31/2027
- b) AC25B01
- Exp.: 2/28/2027
- AC25C01
- c) AC25C01
- d) AC25C01
- e) AC25C01
- Exp.: 3/31/2027.
UPCs (5)
- 0180410000187
- 0635515995055
- 041163251144
- 041220437467
- 036800036406
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · K.C. Pharmaceuticals, Inc.
See all →- SevereK.C. Pharmaceuticals Recalls Leader Ultra Lubricating Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Artificial Tears Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Multiple Brands of Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Same hazard · sterility
See all →- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereCarolina Infusion Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereApothecary Pharma Recalls Tirzepatide Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereApothecary NAD+ Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereK.C. Pharmaceuticals Recalls Good Sense Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- HighGoodSense original formula eye drops recalled over sterility assurance
FDA (Drugs) · 2026-04-08
- HighQuality Choice irritation relief eye drops recalled over sterility assurance
FDA (Drugs) · 2026-04-08
- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Dry Eye Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14